JPRN-UMIN000005138招募中1 期
Donor NK cell infusion for patients after allogeneic hematopoietic stem cell transplantation - Donor NK cell infusion for patients after allogeneic hematopoietic stem cell transplantation
Hematology, Hyogo College of Medicine0 个研究点目标入组 9 人开始时间: 2011年2月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The performance status is grater or equal to grade 2 (ECOG standard). The patient is on graft-versus-host disease. The patient has severe damages on heart, lung, kidney and liver.
研究者
相似试验
已完成
不适用
Infusion of ex vivo-cultured allogeneic NK cells in acute myeloid leukemia patients not eligible for stem cell transplantation (a phase I dose escalation study)Blood cancer10024324Acute Myeloid LeukemiaNL-OMON38045niversitair Medisch Centrum Sint Radboud15
已完成
1 期
Adoptive immunotherapy using donor liver NK cells for preventing recurrence of hepatocellular carcinoma after liver transplantatioHepatocellular carcinomaJPRN-UMIN000012162Hiroshima University50
已完成
1 期
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsUnspecified Adult Solid Tumor, Protocol SpecificLymphomaLeukemiaNCT00823524Asan Medical Center47
尚未招募
不适用
K cells as post consolidation therapie in AML.Hematopoietic stem cells, umbilical cord blood, NK cells, ex vivo expansion, cellular immunotherapy,acute myeloid leukemia, cancer immunotherapy, Elderly patients, Phase I, dose escalation study, safety and toxicity.Hematopoietische stamcellen, navelstrengbloed, NK cellen, ex vivo expansie, cellulaire immunotherapie, acute myeloide leukemie, immunotherapie tegen kanker, oudere patiënten, fase I dosis escalatie studie, veiligheid en toxiciteit.NL-OMON22174Radboud University Nijmegen Medical Centre15
招募中
2 期
Prophylactic infusion of NK cell and gamma/delta chain positive T cell from transplantation donor for poor prognostic or refractory hematologic malignancy and solid tumor -Ibaraki Children's Hospital phase II studyJPRN-UMIN000028370Ibaraki Children's Hospital10